---
title: "Clinical Setting of Neutropenia-Febrile-High-Risk"
date: "2023-02-07"
enableToc: false
---

> [!info] 
> 
> ðŸŒ±ä¾†è‡ª: [[Neutropenia-Febrile-High-Risk]]

# Clinical Setting of Neutropenia-Febrile-High-Risk

*   Febrile neutropenia: Post-cancer chemotherapy or post-allogeneic bone marrow transplant patient with fever (â‰¥38.3Â°C x 1 hr of sustained over 38Â°C) AND neutropenic (absolute neutrophil count range from <500-<1000 cells/Î¼L)
*   High risk: Inpatient status at time of development of fever, significant medical comorbidity or clinically unstable, anticipated neutropenia of â‰¤100 cells/Î¼L and â‰¥ 7 days, hepatic or renal insufficiency, uncontrolled/progressive cancer, pneumonia or other complex infections, mucositis grade 3-4, MASCC Risk Index score of < 21, Alemtuzumab.

